Yuyu Pharma Inc Working Capital to Net Assets Ratio
Yuyu Pharma Inc working capital to net assets ratio. Yuyu Pharma Inc (000225) has a Working Capital to Net Assets ratio of 29.5% as of June 2026. Working capital of ₩43.11 Billion (current assets of ₩91.42 Billion minus current liabilities of ₩48.31 Billion) is measured against net assets of ₩146.18 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Yuyu Pharma Inc (2014–2025)
Working capital to net assets ratio of Yuyu Pharma Inc from 2014 to 2025. This chart shows how Yuyu Pharma Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 29.5%, reflecting working capital of ₩43.11 Billion against net assets of ₩146.18 Billion KRW. Explore Yuyu Pharma Inc (000225) long-term investment share to see how much of total assets are deployed in long-term investments.
Yuyu Pharma Inc Working Capital to Net Assets Ratio by Year (2014–2025)
Yuyu Pharma Inc working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Yuyu Pharma Inc from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Yuyu Pharma Inc asset portfolio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 27.0% | ₩37.97 Billion | ₩140.54 Billion | ₩96.91 Billion | ₩58.95 Billion | ▼ -0.7 pp |
| 2024 | 27.7% | ₩37.47 Billion | ₩135.06 Billion | ₩101.95 Billion | ₩64.48 Billion | ▼ -15.1 pp |
| 2023 | 42.9% | ₩51.62 Billion | ₩120.36 Billion | ₩101.60 Billion | ₩49.98 Billion | ▲ +16.9 pp |
| 2022 | 26.0% | ₩32.04 Billion | ₩123.37 Billion | ₩96.36 Billion | ₩64.32 Billion | ▼ -27.5 pp |
| 2021 | 53.5% | ₩68.87 Billion | ₩128.69 Billion | ₩98.89 Billion | ₩30.01 Billion | ▲ +14.2 pp |
| 2020 | 39.4% | ₩46.07 Billion | ₩117.04 Billion | ₩64.47 Billion | ₩18.40 Billion | ▲ +14.4 pp |
| 2019 | 24.9% | ₩22.56 Billion | ₩90.54 Billion | ₩65.05 Billion | ₩42.50 Billion | ▼ -22.4 pp |
| 2018 | 47.3% | ₩41.08 Billion | ₩86.87 Billion | ₩68.87 Billion | ₩27.79 Billion | ▲ +13.5 pp |
| 2017 | 33.8% | ₩27.99 Billion | ₩82.83 Billion | ₩63.47 Billion | ₩35.48 Billion | ▲ +1.3 pp |
| 2016 | 32.5% | ₩25.45 Billion | ₩78.29 Billion | ₩56.64 Billion | ₩31.19 Billion | ▲ +5.6 pp |
| 2015 | 26.9% | ₩19.81 Billion | ₩73.73 Billion | ₩49.02 Billion | ₩29.21 Billion | ▼ -4.8 pp |
| 2014 | 31.7% | ₩22.67 Billion | ₩71.49 Billion | ₩45.57 Billion | ₩22.90 Billion | — |